Dr. Lighter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 1st Ave
New York, NY 10016Phone+1 917-884-5105
Summary
- Dr. Jennifer Lighter is a Hospital epidemiologist and pediatric infectious disease specialist in New York, NY and is affiliated with NYU Langone Hospitals. She received her medical degree from George Washington University School of Medicine and has been in practice 16 years. She is experienced in tuberculosis, epidemiology, and antimicrobial stewardship.
Education & Training
- NYU Grossman School of MedicineFellowship, Pediatric Infectious Diseases, 2005 - 2008
- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 2001 - 2004
- George Washington University School of Medicine and Health SciencesClass of 2001
Certifications & Licensure
- NY State Medical License 2003 - 2025
Clinical Trials
- Retapamulin as a Decolonizing Agent for MRSA Start of enrollment: 2017 Dec 01
Publications & Presentations
PubMed
- 7 citationsHospital and ICU Admission Risk Associated With Comorbidities Among Children With COVID-19 Ancestral Strains.Stephanie P Ungar, Sadie Solomon, Anna Stachel, Gail F Shust, Katharine N Clouser
Clinical Pediatrics. 2023-10-01 - 2 citationsThe impact of COVID-19 monoclonal antibodies on clinical outcomes: A retrospective cohort study.Arielle R Nagler, Leora I Horwitz, Simon Jones, Christopher M Petrilli, Eduardo Iturrate
American Journal of Health-System Pharmacy. 2022-12-05 - 7 citationsClinical and genomic signatures of SARS-CoV-2 Delta breakthrough infections in New York.Ralf Duerr, Dacia Dimartino, Christian Marier, Paul Zappile, Samuel Levine
Ebiomedicine. 2022-08-01
Journal Articles
- Preventing Infections in Children with CancerLighter-Fisher, J, Pediatrics in Review, 6/2016
- Safety and effectiveness of intravenous pentamidine for prophylaxis of Pneumocystis jirovecii pneumonia in pediatric hematology/oncology patientsSolodokin L, Klejmont L, Scipione M, Dubrovskaya Y, Lighter-Fisher J, Journal of Pediatric Hematology and Oncology, 5/2016
- Engaging Frontline Staff: (Inadvertent) Staff Deployment Motivates Involvement and Awareness of CLABSI Prevention PracticeRosenberg R, Bock S, Dugan C, Devins L, Geraghty G, Transou M, Phillips M, Lighter-Fisher J, Joint Commission Journal on Quality & Patient Safety, 9/2015
- Join now to see all
Other
- New York TimesJennifer Lighter
https://www.nytimes.com/2019/09/22/opinion/anti-vaccine-parents.html?smid=nytcore-ios-share
Press Mentions
- RSV Is Spreading Among Children—Here’s Why & When to See a DoctorNovember 14th, 2022
- Check This CDC Map to See if You Live in a ‘High Risk’ Flu StateNovember 14th, 2022
- Europe Seeing Signs of Another COVID Wave: Should US Worry?October 13th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: